The characteristics and epidemiology of Mycoplasma pneumoniae.
Mycoplasma pneumoniae is a bacterium that causes acute respiratory illness ranging in severity from mild respiratory illness to severe pneumonia.
Mycoplasma pneumoniae infection can be fatal for a small number of people and has rarely been associated with severe complications such as encephalitis.
Most laboratory reports are of infection in children aged from 5 to 14 years, and adults aged 30 to 39 years. The infection is found in patients of all ages, including children under 5 years and occasionally in adults aged 65 years and over.
There is no vaccine against Mycoplasma pneumoniae but it is susceptible to a range of antibiotics. Antimicrobial resistance to macrolides is increasing globally.
The Respiratory and vaccine preventable bacteria reference unit (RVPBRU) offers confirmatory testing of mycoplasma infection.
Published: 10 September 2008
Updated: 27 July 2017
- Added 'Laboratory reports of Mycoplasma pneumoniae for January to June 2017'.
- Added link to guidance for referring specimens for confirmation of Mycoplasma pneumoniae.
- Mycoplasma data summary tables for January to March 2017 uploaded.
- Annual summary of Mycoplasma pneumoniae laboratory surveillance data, 2016, England and Wales uploaded.
- Updated mycoplasma tables.
- Laboratory reports of Mycoplasma pneumoniae infection made to CIDSC from PHE and NHS laboratories in England and Wales: April to June 2016, has been uploaded.
- Added laboratory reports of Mycoplasma pneumoniae infection made to CIDSC from PHE and NHS laboratories in England and Wales: January to March 2016.
- Added 2015 annual report of Mycoplasma pneumoniae laboratory surveillance data for England and Wales.
- Added laboratory reports of Mycoplasma pneumoniae infection in England and Wales: January 2010 to September 2015.
- First published.